Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
3.030
+0.530 (21.20%)
At close: Mar 17, 2026, 4:00 PM EDT
3.000
-0.030 (-0.99%)
Pre-market: Mar 18, 2026, 7:16 AM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Biotechnology
4.53M5.72M5.75M4.78M4.78M
Biotechnology Growth
-20.71%-0.50%20.18%0.04%132.04%
Total
4.53M5.72M5.75M4.78M4.78M
Total Growth
-20.71%-0.50%20.18%0.04%132.04%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
4.53M5.72M5.75M4.78M4.78M
United States Growth
-20.71%-0.50%20.18%0.04%132.04%
Total
4.53M5.72M5.75M4.78M4.78M
Total Growth
-20.71%-0.50%20.18%0.04%132.04%
Source: S&P Global Market Intelligence.